Literature DB >> 23974991

Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009.

Jennifer C C Debruyn1, Ing Shian Soon, James Hubbard, Iwona Wrobel, Remo Panaccione, Gilaad G Kaplan.   

Abstract

BACKGROUND: Data are limited on temporal trends in outcomes of hospitalization and surgery in pediatric Crohn's disease (CD) and ulcerative colitis (UC). Thus, we evaluated the U.S. nationwide temporal trends for incidence of hospitalization and intestinal resection along with associated resource utilization.
METHODS: We used the Kids' Inpatient Database (1997, 2000, 2003, 2006, and 2009) to identify all admissions for children aged 18 years or younger with a primary CD (International Classification of Diseases, Ninth Revision [ICD-9]: 555.X) or UC (ICD-9: 556.X) diagnosis or a secondary CD or UC diagnosis and procedural code of intestinal resection. Poisson regression analysis was performed to evaluate time trends in the incidence of hospitalization, intestinal resection, and hospital resource utilization.
RESULTS: The annual incidence of hospitalization was 5.7 and 3.5 per 100,000 children for CD and UC, respectively, with significant increases over time for CD (annual percent increase [API], 3.8%; 95% confidence interval [CI], 3.0%-4.5%) and UC (API, 4.5%; 95% CI, 4.3%-4.7%). Median hospital days per hospitalization for CD and UC remained stable, whereas median charge per hospitalization increased for CD (API, 4.1%; 95% CI, 2.6%-5.6%) and UC (API, 4.7%; 95% CI, 3.5%-5.9%). The annual incidence of intestinal resection remained stable for UC at 0.6 per 100,000 children but climbed for CD (API, 2.1%; 95% CI, 0.1-4.2).
CONCLUSIONS: The annual incidence of hospitalization is climbing in pediatric inflammatory bowel diseases, accompanied by rising intestinal resection rates for CD and stable colectomy rates for UC. With escalating resource utilization, the economic and health burden of pediatric inflammatory bowel diseases is substantial.

Entities:  

Mesh:

Year:  2013        PMID: 23974991     DOI: 10.1097/MIB.0b013e3182a56148

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  17 in total

1.  Weekend Surgical Admissions of Pediatric IBD Patients Have a Higher Risk of Complication in Hospitals Across the US.

Authors:  Matthew D Egberg; Joseph A Galanko; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2020-01-06       Impact factor: 5.325

2.  Increasing hospitalizations in inflammatory bowel disease among children in the United States, 1988-2011.

Authors:  Kelly C Sandberg; Matthew M Davis; Achamyeleh Gebremariam; Jeremy Adler
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

3.  The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease.

Authors:  Edward L Barnes; Bharati Kochar; Millie D Long; Christopher F Martin; Seth D Crockett; Joshua R Korzenik; Michael D Kappelman
Journal:  J Pediatr       Date:  2017-10-14       Impact factor: 4.406

4.  Postoperative Use of Biologics was Less Common among Patients with Crohn's Disease With Emergent/Urgent Versus Elective Intestinal Resection.

Authors:  Joehl T Nguyen; Edward L Barnes; Carolyn T Thorpe; Karyn B Stitzenberg; Casey R Tak; Alan C Kinlaw
Journal:  Gastro Hep Adv       Date:  2022-06-13

5.  The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018.

Authors:  Yi-Ming He; Ren Mao; Gang Yuan; Rui-Ming Liang; Jian-Yan Long; Xiao-Qi Ye; Marietta Iacucci; Subrata Ghosh; Shomron Ben-Horin; Gilaad G Kaplan; Yao He; Joseph J Y Sung; Sui Peng; Hai-Bo Wang; Min-Hu Chen
Journal:  Therap Adv Gastroenterol       Date:  2022-06-13       Impact factor: 4.802

6.  A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease.

Authors:  Mahmoud H Mosli; Othman Al-Harbi; Brian G Feagan; Majid A Almadi
Journal:  Saudi J Gastroenterol       Date:  2015 Jul-Aug       Impact factor: 2.485

Review 7.  Pediatric Crohn's Disease.

Authors:  Daniel von Allmen
Journal:  Clin Colon Rectal Surg       Date:  2018-02-25

8.  Progression to colectomy in the era of biologics: A single center experience with pediatric ulcerative colitis.

Authors:  Faith D Ihekweazu; Tatiana Fofanova; Ryan Palacios; Avanthi Ajjarapu; Lina Karam; Adam M Vogel; J R Rodriguez; Richard Kellermayer
Journal:  J Pediatr Surg       Date:  2020-02-03       Impact factor: 2.545

9.  Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.

Authors:  Edward L Barnes; Bharati Kochar; Millie D Long; Christopher F Martin; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2017-12       Impact factor: 7.290

Review 10.  Impact of Modern Drug Therapy on Surgery: Crohn's Disease.

Authors:  Peter Kienle
Journal:  Visc Med       Date:  2018-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.